<DOC>
	<DOCNO>NCT00651859</DOCNO>
	<brief_summary>This study evaluate safety efficacy once-daily bimatoprost 0.03 % 0.01 % ophthalmic solution compare once-daily administer bimatoprost vehicle ophthalmic solution 2 week ethnically Japanese patient open-angle glaucoma ocular hypertension</brief_summary>
	<brief_title>Safety Efficacy Study Bimatoprost Ethnically Japanese Patients With Open-Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Ethnically Japanese patient glaucoma ocular hypertension eye require IOPlowering therapy eye Uncontrolled systemic disease Use bimatoprost ocular prostaglandin ( eg , latanoprost , travoprost ) within 6 week prior baseline ( Day 0 )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>